Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Khamesipour

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Expert Opinion on Biological Therapy|August 1, 2014
Therapeutic vaccines for leishmaniasisAli Khamesipour
Current Drug Safety|April 11, 2015
The need to teach vaccine safety to basic scientists and public health officialsAli Khamesipour
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 25, 2012
One swallow doesn’t bring spring. Response to letter to editorAli Khamesipour, Reza Jafari Shakib
Medical Microbiology and Immunology|May 2, 2021
Potential biomarkers of immune protection in human leishmaniasisMahmoud Nateghi Rostami, Ali Khamesipour
Iranian Journal of Pharmaceutical Research : IJPR|September 3, 2015
Computational Study of Quinolone Derivatives to Improve their Therapeutic Index as Anti-malaria Agents: QSAR and QSTRMaryam Iman, Asghar Davood, Ali Khamesipour
Acta Tropica|September 17, 2019
An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccinesMehdi Mohebali, Abolhassan Nadim, Ali Khamesipour
Expert Opinion on Drug Delivery|January 10, 2020
Development of nano-carriers for <i>Leishmania</i> vaccine deliveryAnis Askarizadeh, Ali Badiee, Ali Khamesipour
European Journal of Dermatology : EJD|March 11, 2005
Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. majorBabak Shazad, Babak Abbaszadeh, Ali Khamesipour
Parasitology Research|December 3, 2010
Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODNMohsen Tafaghodi, Ali Khamesipour, Mahmoud R Jaafari
Journal of Ethnopharmacology|October 11, 2005
Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatmentTooba Ghazanfari, Zuhair M Hassan, Ali Khamesipour
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Expert Opinion on Biological Therapy|August 1, 2014
Therapeutic vaccines for leishmaniasisAli Khamesipour
Current Drug Safety|April 11, 2015
The need to teach vaccine safety to basic scientists and public health officialsAli Khamesipour
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 25, 2012
One swallow doesn’t bring spring. Response to letter to editorAli Khamesipour, Reza Jafari Shakib
Medical Microbiology and Immunology|May 2, 2021
Potential biomarkers of immune protection in human leishmaniasisMahmoud Nateghi Rostami, Ali Khamesipour
Iranian Journal of Pharmaceutical Research : IJPR|September 3, 2015
Computational Study of Quinolone Derivatives to Improve their Therapeutic Index as Anti-malaria Agents: QSAR and QSTRMaryam Iman, Asghar Davood, Ali Khamesipour
Acta Tropica|September 17, 2019
An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccinesMehdi Mohebali, Abolhassan Nadim, Ali Khamesipour
Expert Opinion on Drug Delivery|January 10, 2020
Development of nano-carriers for <i>Leishmania</i> vaccine deliveryAnis Askarizadeh, Ali Badiee, Ali Khamesipour
European Journal of Dermatology : EJD|March 11, 2005
Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. majorBabak Shazad, Babak Abbaszadeh, Ali Khamesipour
Parasitology Research|December 3, 2010
Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODNMohsen Tafaghodi, Ali Khamesipour, Mahmoud R Jaafari
Journal of Ethnopharmacology|October 11, 2005
Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatmentTooba Ghazanfari, Zuhair M Hassan, Ali Khamesipour
Pageof 20